Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer

por Bartoloni, Stefania, Leone, Stefano, Acconcia, Filippo
Publicado 2020

A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary a...

por Cipolletti, Manuela, Leone, Stefano, Bartoloni, Stefania, Acconcia, Filippo
Publicado 2023

The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)‐positive breast cancer cells

por Bartoloni, Stefania, Leone, Stefano, Pescatori, Sara, Cipolletti, Manuela, Acconcia, Filippo
Publicado 2022

A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells

por Cipolletti, Manuela, Bartoloni, Stefania, Busonero, Claudia, Parente, Martina, Leone, Stefano, Acconcia, Filippo
Publicado 2021

Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells

por Pescatori, Sara, Leone, Stefano, Cipolletti, Manuela, Bartoloni, Stefania, di Masi, Alessandra, Acconcia, Filippo
Publicado 2022

Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer

por Busonero, Claudia, Leone, Stefano, Bianchi, Fabrizio, Maspero, Elena, Fiocchetti, Marco, Palumbo, Orazio, Cipolletti, Manuela, Bartoloni, Stefania, Acconcia, Filippo
Publicado 2020